Prolonged-release Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia: a Randomized Clinical Trial

Trial Profile

Prolonged-release Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia: a Randomized Clinical Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2014

At a glance

  • Drugs Melatonin (Primary) ; Antipsychotics; Benzodiazepines
  • Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia; Sleep disorders
  • Focus Therapeutic Use
  • Acronyms SMART
  • Most Recent Events

    • 19 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Nov 2012 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 25 Oct 2011 Actual initiation date changed from 3 May 2011 to Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top